COPD Study

Sunshine Melbourne

Please note that this study has now closed. However, we encourage you to pre-register your interest for upcoming respiratory studies here.

Description

What to expect

Study details

Ages

40 to 80 years old

Duration

Approx 3 years with 11 clinic visits (a mix of in clinic and virtual visits)

Compensation

Study treatments and procedures will be provided free of charge and participants will be reimbursed for reasonable expenses associated with study visits.

Eligibility Criteria

You may be eligible to take part if you:

Are between 40-80 years old.
Have been diagnosed with COPD, chronic bronchitis or emphysema.
Are a current or former smoker.

AND

Have established cardiovascular disease e.g you have a history of heart attacks, blocked
arteries, heart failure, heart bypass.
OR Are at risk for a first cardiovascular event e.g you suffer from high blood pressure, diabetes, high cholesterol.

Please note: Participants who have used inhaled steroids within the last 12-months or have an active diagnosis of asthma will be ineligible.

Locations

Sunshine Melbourne

Description

Chronic Obstructive Pulmonary Disease (COPD) is a lung condition that makes it hard to breathe. It can also be called chronic bronchitis or emphysema.

Symptoms include shortness of breath, wheezing, chest tightness, and coughing. COPD gets worse over time and whilst there is no cure, treatments can help manage symptoms and improve quality of life.

Studies have shown that using a combination of inhaled medications may be more effective in reducing exacerbations, or flare-ups and improving lung function compared to using just one type of medicine.

What to expect

Here at Momentum, we are conducting a study that will explore the efficacy of an investigational combination of medications to prevent serious heart and lung issues in people with COPD.

Study treatments and procedures will be provided free of charge and participants will be reimbursed for reasonable expenses associated with study visits.

The study has an approximate duration of 3 years and involves 11 visits (both virtual and clinic visits).

Please note that this study has now closed. However, we encourage you to pre-register your interest for upcoming respiratory studies here.

Home
Clinical Trials
COPD Study Melbourne 59

COPD Study

Sunshine Melbourne

Please note that this study has now closed. However, we encourage you to pre-register your interest for upcoming respiratory studies here.

Description

What to expect

Study details

Ages

40 to 80 years old

Duration

Approx 3 years with 11 clinic visits (a mix of in clinic and virtual visits)

Compensation

Study treatments and procedures will be provided free of charge and participants will be reimbursed for reasonable expenses associated with study visits.

Eligibility Criteria

You may be eligible to take part if you:

Are between 40-80 years old.
Have been diagnosed with COPD, chronic bronchitis or emphysema.
Are a current or former smoker.

AND

Have established cardiovascular disease e.g you have a history of heart attacks, blocked
arteries, heart failure, heart bypass.
OR Are at risk for a first cardiovascular event e.g you suffer from high blood pressure, diabetes, high cholesterol.

Please note: Participants who have used inhaled steroids within the last 12-months or have an active diagnosis of asthma will be ineligible.

Locations

Sunshine Melbourne

Description

Chronic Obstructive Pulmonary Disease (COPD) is a lung condition that makes it hard to breathe. It can also be called chronic bronchitis or emphysema.

Symptoms include shortness of breath, wheezing, chest tightness, and coughing. COPD gets worse over time and whilst there is no cure, treatments can help manage symptoms and improve quality of life.

What to expect

Here at Momentum, we are conducting a study that will explore the efficacy of an investigational combination of medications to prevent serious heart and lung issues in people with COPD.

Study treatments and procedures will be provided free of charge and participants will be reimbursed for reasonable expenses associated with study visits.

The study has an approximate duration of 3 years and involves 11 visits (both virtual and clinic visits).

Please note that this study has now closed. However, we encourage you to pre-register your interest for upcoming respiratory studies here.